Crownbridge Group is developing an institution built on sound judgment, accountable leadership and responsible enterprise ownership. Our governance arrangements are evolving alongside the Group’s businesses.
This page sets out our direction and proposed Group Board framework. It does not announce a fully constituted board, appointed independent directors or operating board committees. Formal terms, appointments and policies will be published as they are approved.
Our vision
To build a trusted international group that strengthens institutions, develops resilient enterprises and creates enduring value through principled leadership.
Our mission
To bring together strategic advice, disciplined capital and governance expertise to help leaders navigate complexity, strengthen organisational capability and build businesses that endure.
Our values and governance principles
- Integrity: communicate accurately, honour commitments and address conflicts openly.
- Accountability: give decisions a named owner, clear authority and a documented basis.
- Independent judgment: encourage constructive challenge and decisions supported by evidence.
- Stewardship: protect financial, human, intellectual and information resources for the long term.
- Respect: consider clients, employees, partners and communities in how we build and operate.
- Proportionality: match controls and oversight to the scale, maturity and risk of each business.
The evolving Group Board of Directors
The intended Group Board will provide strategic direction, oversee executive performance and hold leadership accountable for risk, capital allocation and conduct. Membership should combine relevant commercial, financial, sector and governance experience, with independent challenge introduced as the Group develops.
The Chair’s oversight role and the Group Chief Executive’s delivery responsibilities should be clearly defined. Where roles are combined during the early stage, the arrangement and measures for independent challenge should be documented. Director names, biographies and appointment status will be added once confirmed.
Proposed Board terms of reference
The following is a framework for formal approval, rather than a representation that a Board charter has already been adopted.
- Purpose and authority: oversee Group strategy and performance within the powers of the relevant legal entity, its constitutional documents and applicable duties.
- Composition and appointment: document appointment, tenure, induction, succession and the skills required for effective oversight.
- Meetings: plan quarterly meetings, with additional meetings for material decisions. Circulate agendas and decision papers in advance; record decisions, dissent and actions.
- Quorum and decisions: specify quorum, voting and written-decision arrangements in the formally approved charter, consistent with the entity’s constitution. Conflicted members should not participate where exclusion is required.
- Information and assurance: receive timely financial, operational, people, risk and compliance reporting; obtain specialist advice where needed.
- Evaluation: review Board effectiveness, director development and these terms at least annually.
Matters proposed for Board reservation
- Group strategy, annual plans, budgets and material changes to the business model.
- Acquisitions, disposals, new subsidiaries and material partnerships.
- Material capital expenditure, borrowing, guarantees and funding commitments.
- Senior executive appointments, succession and remuneration principles.
- Risk appetite, material disputes, related-party transactions and significant policy changes.
- Approval of accounts and material external corporate announcements.
Financial thresholds and entity-specific approval rules should be set in a formally approved schedule. No monetary approval limits are asserted here.
Delegation and subsidiary oversight
A written authority matrix should distinguish shareholder decisions, Group Board reservations, executive responsibilities and subsidiary-level authority. Each business should retain clear accountability for its own contracts, licences, records and operations. Group oversight should respect the responsibilities of each entity’s directors.
Crownbridge Capital’s acquisition of AstraNova Life Sciences is the Group’s first corporate acquisition. AstraNova remains an early-stage business. Crownbridge Capital has also acquired LUMIRAX as a distinct early-stage software business. Corvanta Care and Clinoryx Technologies also belong to Crownbridge Group as separate care-provider and clinical-technology companies. Each business’s governance and development milestones should be monitored separately from the Group’s advisory activity. Read the LUMIRAX acquisition announcement. Read the acquisition announcement.
Conflicts, ethics and information boundaries
The intended framework includes declarations of interests, a conflicts register, recusal from affected decisions, documented review of related-party arrangements and clear separation between confidential client information and investment interests. Anti-bribery, gifts and hospitality, responsible procurement and protected reporting arrangements should form part of the policy programme.
Risk, assurance and responsible growth
Priorities include proportionate financial controls, liquidity oversight, data protection, cybersecurity, responsible AI use, business continuity, people oversight and accurate public reporting. As complexity increases, the Board should consider whether dedicated audit and risk, investment, and nominations and remuneration committees are justified. These committees are not presented as already established.
Governance development priorities
- Confirm the legal entity structure, ownership and accountable leadership for each business.
- Approve the Board charter, reserved-matters schedule and delegated-authority matrix.
- Confirm Board appointments and publish accurate leadership profiles.
- Establish the reporting calendar, risk register, conflicts register and policy approval record.
- Introduce proportionate performance reporting, succession planning and annual governance review.
Transparency and contact
Public information should reflect confirmed appointments, completed transactions and actual operating readiness. Governance questions can be directed to the Crownbridge Executive Office. Enquiries will be routed appropriately; the general enquiry form is not described as an independent whistleblowing channel.
CONTACT THE EXECUTIVE OFFICE ↗